Scientific Programme

20th Meeting of the European Venous Forum

    • in collaboration with the Swiss Society of Phlebology’
    • Zurich University, Zurich, Switzerland
  • 27-29 June 2019

Provisional Scientific Programme

Click here to view the online programme



08.00-08.30 Video Session Chair: Andrew Nicolaides, Dominik Heim
08.30-10.30 Abstract Session 1: Venous Thromboembolism

(10 minute presentation, 10 minute discussion)

10.30-11.00 Refreshments and visit to Exhibition  |  Visit Poster Presentations
11.00-12.00 Didactic Session 1: Superficial Veins. That’s why I prefer

  • 11.00: Foam. Philippe Kern (CH)
  • 11.08: Surgery. Jurg Traber (CH)
  • 11.16: Thermal Ablation. Lowell Kabnik (USA)
  • 11.24: Non-Thermal Ablation. Heiko Uthoff (CH)
  • 11.32-11.45: Open Debate with Audience
  • 11.45-12.00: Signs and Symptoms due to Systemic Disorders that can mimic Chronic Venous Disease. Daciana Branisteanu (Romania)
12.00-13.20 Abstract Session 2: Compression

(10 minute presentation, 10 minute discussion)

13.20-14.20 Lunch and visit to Exhibition  |  ePoster Presentations
13.45-14.15 Meet the Experts Session 1: The Open Leg.Chairman: Alfred Obermayer (Austria)

  • Careful: This is not a venous ulcer! Jürg Hafner (CH)
  • How ESCHAR and EVRA can be interpreted in current clinical practice in patient selection for treatment. Alun Davies (UK)
14.20-15.20 Industry Session 1
15.20-16.40 Abstract Session 3: Laser Thermal Ablation

(10 minute presentation, 10 minute discussion)

16.40-17.00 Refreshments and visit to Exhibition  |  Visit e-Poster Presentations
17.00-18.20 Abstract Session 4: Diagnostic Tests, Venous Ablation by Ultrasound and Sclerotherapy

(10 minute presentation, 10 minute discussion)

18.20 Opening Ceremony
19.00-20.00 Welcome Reception. Exhibition Areas


08.00-08.30 Varicose Veins. Presentation of patients. What would you do?
08.30-10.30 Abstract Session 5: Pathophysiology, Epidemiology and Surveys

(10 minute presentation, 10 minute discussion)

10.30-11.00 Refreshments and visit to Exhibition  |  Visit e- Poster Presentations
11.00-12.00 Industry Session 2
12.00-12.30 EVF Invited Lecture: Why venous ulcers have difficulties to heal: A pathophysiological review.Joseph D Raffetto (USA)  
12.30-13.30 Didactic Session 2Lymphatics.

(10 minute presentation, 5 minute discussion)

  • 12.30-12.45: The relationship between venous diameters, clinical severity and quality of life. A systematic review. Matthew Tan (UK) 
  • 12.45-13.00: Research: Here we are at the moment. Jean Paul Belgrado (Belgium)
  • 13.00-13.15: Treatment by conservative means. Daniela Reutter (CH)
  • 13.15-13.30: If all fails, surgery? Nicole Lindenblatt (CH) 
13.30-14.30 Lunch and visit to Exhibition  |  ePoster Presentations
14.00-14.30 Meet the Experts Session 2: How to deal with problems in the Treatment of Varicose Veins

  • 14.00-14.15: SFJ insufficiency and reflux into the AASV. Marianne De Maeseneer (Belgium)
  • 14.15-14.30: Is redo high ligation dead? Olle Nelzen (Sweden)
14.30-15.00 EVF Annual General Meeting (Members Only)
15.00-16.40 Prize winning papers from the American Venous Forum, American College of Phlebology and the Japanese Society of Phlebology (10 minute presentation, 10 minute discussion)
2 Presentations from American Venous Forum (AVF)
Presentation from American Vein and Lymphatic Society (AVLS) (formerly American College of Phlebology.
A population-based assessment of mortality in patients with varicose veins. Thom Rooke1, Cindy Felty2, David Liedl1, Christina Wood-Wintz2

Mayo Clinic, Rochester, Minnesota, USA

2 Presentations from Japanese Society of Phlebology (JSP)
16.00-16.20 Results of surgical treatments for venous stasis ulcers

Atsushi Tabuchi, Yasuhiro Yunoki, and Kazuo Tanemoto

Department of Cardiovascular Surgery, Kawasaki Medical School, Kurashiki, Japan

16.20-16.40 Clinical Characteristics, Management Strategies, and Long-Term Outcomes of Asymptomatic Lower Extremity Deep Vein Thrombosis in Patients with Active Cancers

Yugo Yamashita

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

16.40-17.10 Refreshments and visit to Exhibition  |  Visit to e-Poster Presentations
17.10-19.10 Didactic Session 3: Venous Thromboembolism (14 minute presentation, 10 minute discussion)

  • 17.10-17.34: Why ATTRACT is not the end of iliofemoral thromboslyis. Stephen Black (UK)
  • 17.34-17.58: Is QOL score important after thrombus removal, or is patency and Villalta enough? Niels Baekgaard (Denmark)
  • 17.58-18.22: Postthrombotic syndrome. Long-term follow up. The Basel series. Christina Jeanneret (CH)
  • 18.22-18.46: The challenge of diagnosing pulmonary embolism. Marc Righini (CH)
  • 18.46-19.10: Everything you always wanted to know about DOAC/NOAC. Michael Nagler (CH)
20.00 Congress Dinner


08.30-09.30 Didactic Session 4: Compression. (10 minute presentation, 5 minute discussion)

  • 08.30-08.45: Velcro. A real revolution in compression therapy? Giovanni Mosti (Italy)
  • 08.45-09.00: Intermittent pressure compression: Just nice to have? Eberhard Rabe (Germany)
  • 09.00-09.15: Towards a patient-friendly compression therapy. Jürg Hafner (CH)
  • 09.15-09.30: Elastic compression therapy for prevention of post-thrombotic syndrome : How long is long enough? Arina J ten Cate-Hoek (Netherlands)
09.30-10.30 Industry Session 3:
10.30-11.00 Refreshments and visit to Exhibition  |  Visit Poster Presentation
11.00-12.00 Abstract Session 6: Miscellaneous

 (10 minute presentation, 5 minute discussion)

12.00-13.00 Joint session: European Venous Forum and American Venous forum: Where do we go from here – A glimpse into the future?(12 minute presentation, 3 minute discussion)

  • Why this session? Dominik Heim, Switzerland
  • 12.00-12.15: The rationale of compression Werner Blättler (CH) (EVF/ SGP)
  • 12.15-12.30: The link between morphology and iliac veins and outcomes: Does shape matter? Lowell Kabnick (USA) (AVF)
  • 12.30-12.45: Recurrence after endovenous treatment.  Treatment options.  Lars Rasmussen (Denmark) (EVF)
  • 12.45-13.00: Appropriateness of venous procedures and its potential impact on office practices. Elna Masuda (USA) (AVF)
13.00-13.15 Closing Remarks  |  Presentation of EVF 2020

Comments are closed.